Terug
Dagbereik
€ 16,26
€ 16,29
52-Weeksbereik
€ 11,65
€ 18,61
Volume
1.855.631
50D / 200D Gem.
€ 15,60
/
€ 14,35
Vorige Slotkoers
€ 16,25
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 13,8 | 0,4 |
| P/B | 1,2 | 2,9 |
| ROE % | 8,6 | 3,7 |
| Net Margin % | 2,7 | 3,9 |
| Rev Growth 5Y % | -3,2 | 10,0 |
| D/E | 2,2 | 0,2 |
Koersdoel Analisten
Hold
€ 18,00
+10.6%
Low: € 17,00
High: € 19,00
Forward K/W
12,9
Forward WPA
€ 1,26
WPA Groei (sch.)
+0,0%
Omzet Sch.
5,7 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 1,51
€ 1,23 – € 1,78
|
6,2 B | 2 |
| FY2027 |
€ 1,39
€ 1,30 – € 1,45
|
6 B | 4 |
| FY2026 |
€ 1,26
€ 1,24 – € 1,29
|
5,7 B | 4 |
Belangrijkste Punten
Revenue declined -3,18% annually over 5 years
Earnings declined -31,69% over the past year
Debt/Equity of 2,17 — high leverage
Generating 382,74M in free cash flow
P/E of 13,80 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8,30%
Groei
Revenue Growth (5Y)
-3,18%
Revenue (1Y)5,12%
Earnings (1Y)-31,69%
FCF Growth (3Y)4,15%
Kwaliteit
Return on Equity
8,63%
ROIC4,64%
Net Margin2,68%
Op. Margin6,14%
Veiligheid
Debt / Equity
2,17
Current Ratio1,04
Interest Coverage2,85
Waardering
P/E Ratio
13,80
P/B Ratio1,18
EV/EBITDA17,02
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,12% | Revenue Growth (3Y) | -9,54% |
| Earnings Growth (1Y) | -31,69% | Earnings Growth (3Y) | -22,51% |
| Revenue Growth (5Y) | -3,18% | Earnings Growth (5Y) | -22,35% |
| Profitability | |||
| Revenue (TTM) | 5,45B | Net Income (TTM) | 146,22M |
| ROE | 8,63% | ROA | 2,50% |
| Gross Margin | 11,54% | Operating Margin | 6,14% |
| Net Margin | 2,68% | Free Cash Flow (TTM) | 382,74M |
| ROIC | 4,64% | FCF Growth (3Y) | 4,15% |
| Safety | |||
| Debt / Equity | 2,17 | Current Ratio | 1,04 |
| Interest Coverage | 2,85 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 13,80 | P/B Ratio | 1,18 |
| P/S Ratio | 0,37 | PEG Ratio | -0,43 |
| EV/EBITDA | 17,02 | Dividend Yield | 0,02% |
| Market Cap | 2,02B | Enterprise Value | 5,70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,45B | 5,19B | 6,66B | 6,33B | 6,20B |
| Net Income | 146,22M | 214,04M | 243,49M | 158,99M | 402,23M |
| EPS (Diluted) | 1,18 | 1,66 | 1,91 | 1,23 | 2,99 |
| Gross Profit | 629,30M | 633,64M | 932,04M | 733,38M | 919,37M |
| Operating Income | 334,58M | 268,32M | 554,87M | 403,28M | 713,77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,85B | 5,61B | 7,69B | 7,67B | 7,36B |
| Total Liabilities | 3,82B | 3,61B | 6,12B | 6,27B | 6,00B |
| Shareholders' Equity | 1,71B | 1,68B | 1,29B | 1,12B | 1,11B |
| Total Debt | 3,70B | 2,70B | 4,52B | 5,16B | 4,76B |
| Cash & Equivalents | 26,52M | 59,69M | 52,63M | 97,91M | 74,31M |
| Current Assets | 1,03B | 1,02B | 1,26B | 1,27B | 1,14B |
| Current Liabilities | 984,49M | 977,65M | 1,25B | 1,16B | 1,27B |